<?xml version="1.0" encoding="UTF-8"?>
<p id="P12">To identify potential drivers of disease pathology, we focused our attention on modules significantly correlated with AsymAD cases, representing the earliest disease phase. This highlighted module C1 (
 <xref rid="F3" ref-type="fig">Figures 3A</xref>–
 <xref rid="F3" ref-type="fig">3G</xref> and 
 <xref rid="SD4" ref-type="supplementary-material">S1B</xref>–
 <xref rid="SD4" ref-type="supplementary-material">S1Q</xref>; 
 <xref rid="SD3" ref-type="supplementary-material">Table S4</xref>) and the C8 and C10 modules, which were upregulated in AsymAD and AD cases (
 <xref rid="F3" ref-type="fig">Figures 3H</xref>–
 <xref rid="F3" ref-type="fig">3W</xref> and 
 <xref rid="SD4" ref-type="supplementary-material">S2</xref>; 
 <xref rid="SD3" ref-type="supplementary-material">Table S4</xref>). C1 represented genes highly expressed in neurons (hypergeometric test; p = 1.0e–23) and was enriched for synaptic processes, consistent with pre- and post-synaptic vesicle hub proteins such as HOMER1, DLG4, and SYT1 (
 <xref rid="F3" ref-type="fig">Figure 3A</xref>). The hub gene SYT1, which mediates synaptic vesicle release, is reduced in human AD brain and has been shown to promote Aβ generation (
 <xref rid="R37" ref-type="bibr">Gautam et al., 2015</xref>; 
 <xref rid="R90" ref-type="bibr">Öhrfelt et al., 2016</xref>; 
 <xref rid="R123" ref-type="bibr">Yoo et al., 2001</xref>).
</p>
